A prospective genetic study of complete and partial hydatidiform moles

Area of Science:

• Reproductive Biology
• Genetics
• Pathology

Background:

• Hydatidiform moles are abnormal pregnancies requiring accurate classification.
• Distinguishing between partial and complete moles is crucial for patient management.
• Genetic analysis offers advanced diagnostic capabilities.

Purpose of the Study:

• To classify 51 partial and 149 complete hydatidiform moles using pathological features and deoxyribonucleic acid (DNA) ploidy.
• To investigate the genetic origins of different mole types, particularly triploidy and androgenesis.
• To correlate mole type with the risk of developing gestational trophoblastic tumors and chemotherapy requirements.

Main Methods:

• Pathologic classification of 202 hydatidiform moles.
• Ploidy analysis using deoxyribonucleic acid (DNA) technology.
• Genetic polymorphism analysis, including locus-specific minisatellite DNA probes.

Main Results:

• Partial moles: 44 triploids (1 maternal, 2 paternal chromosomes), 2 tetraploids, 1 diploid.
• Complete moles: 1 haploid, 1 triploid, 105 diploid/androgenetic (39 homozygous, 13 heterozygous).
• No partial moles progressed to gestational trophoblastic tumors; chemotherapy needs were similar for homozygous and heterozygous complete moles.

Conclusions:

• Deoxyribonucleic acid (DNA) technology accurately refines hydatidiform mole classification.
• Triploid partial moles often result from dispermy (two sperm fertilizing one egg).
• Complete moles exhibit diverse genetic origins, with no significant difference in chemotherapy requirements based on homozygous or heterozygous androgenesis.